These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 34088317)

  • 1. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
    Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.
    Gando S; Nakanishi Y; Tedo I
    Crit Care Med; 1995 Nov; 23(11):1835-42. PubMed ID: 7587259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.
    Meduri GU; Headley S; Kohler G; Stentz F; Tolley E; Umberger R; Leeper K
    Chest; 1995 Apr; 107(4):1062-73. PubMed ID: 7705118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
    Liu Y; Chen D; Hou J; Li H; Cao D; Guo M; Ling Y; Gao M; Zhou Y; Wan Y; Zhu Z
    Cytokine; 2021 Feb; 138():155365. PubMed ID: 33246770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
    Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
    Front Immunol; 2021; 12():691879. PubMed ID: 34163488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
    Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
    Front Immunol; 2021; 12():592727. PubMed ID: 33968010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
    Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
    Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.
    Hoechter DJ; Becker-Pennrich A; Langrehr J; Bruegel M; Zwissler B; Schaefer S; Spannagl M; Hinske LC; Zoller M
    Thromb Res; 2020 Dec; 196():186-192. PubMed ID: 32891904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
    Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
    Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 infection: an overview on cytokine storm and related interventions.
    Montazersaheb S; Hosseiniyan Khatibi SM; Hejazi MS; Tarhriz V; Farjami A; Ghasemian Sorbeni F; Farahzadi R; Ghasemnejad T
    Virol J; 2022 May; 19(1):92. PubMed ID: 35619180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.
    Iglesias-Julián E; López-Veloso M; de-la-Torre-Ferrera N; Barraza-Vengoechea JC; Delgado-López PD; Colazo-Burlato M; Ubeira-Iglesias M; Montero-Baladía M; Lorenzo-Martín A; Minguito-de-la-Iglesia J; García-Muñoz JP; Sanllorente-Sebastián R; Vicente-González B; Alemán-Alemán A; Buzón-Martín L
    J Autoimmun; 2020 Dec; 115():102537. PubMed ID: 32843231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
    Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).
    Hashemian SM; Shafigh N; Afzal G; Jamaati H; Tabarsi P; Marjani M; Malekmohammad M; Mortazavi SM; Khoundabi B; Mansouri D; Moniri A; Hajifathali A; Roshandel E; Mortaz E; Adcock IM
    Pulmonology; 2021; 27(6):486-492. PubMed ID: 33358260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory biomarkers associated with COVID-19 severity and management.
    Keddie S; Ziff O; Chou MKL; Taylor RL; Heslegrave A; Garr E; Lakdawala N; Church A; Ludwig D; Manson J; Scully M; Nastouli E; Chapman MD; Hart M; Lunn MP
    Clin Immunol; 2020 Dec; 221():108614. PubMed ID: 33153974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure.
    Roumen RM; Hendriks T; van der Ven-Jongekrijg J; Nieuwenhuijzen GA; Sauerwein RW; van der Meer JW; Goris RJ
    Ann Surg; 1993 Dec; 218(6):769-76. PubMed ID: 8257227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.